1. Introduction {#s0005}
===============

Traditional Chinese medicine (TCM) is well known to generally exert its therapeutic effects through the synergic effects of its multiple active ingredients and multi-targets. However, hundreds of different constituents with diverse physical and chemical properties coexist, making the quality control (QC) of TCM extremely difficult [@bib1].

Multi-ingredients quantification (MIQ) is usually selected as a QC approach of TCM, but these ingredients can hardly stand for the complex herbal products. Another QC method is fingerprint analysis (FA), which addresses the systematic nature of TCM. However, this strategy can only show results of similarity calculated on the basis of the relative value using a pre-selected marker compound as a reference [@bib2], and the real content of active ingredients cannot be quantified exactly. Although combination of FA and MIQ may be more effective than FA or MIQ alone for the QC of TCM [@bib3], [@bib4], [@bib5], [@bib6], "common peaks" without standard references in FA are usually neglected. The quality difference of medicinal herbs and their products may result from different original production regions, harvest time or manufacturing processes, but existence of "common peaks" may be the basis of their quality consistency, stability and therapeutic effects. Therefore, the quantification and identification of "common peaks" is critically important for controlling the quality of TCM and revealing the material basis of their therapeutic effects. In the present work, a new QC strategy based on quantitative and qualitative analysis of "common peaks" in chemical analysis of TCM was proposed and successfully applied for the QC of Yuanhu Zhitong tablet (YZT).

YZT, a classical TCM prescription consisting of 223 g of Radix *Angelicae dahuricae* and 445 g of Rhizoma *Corydalis* (processed with vinegar), has been clinically used to treat gastralgia, costalgia, headache and dysmenorrhea in China [@bib7]. Alkaloids and coumarins have been generally regarded as the active component of Rhizoma *Corydalis* and Radix *Angelicae dahuricae*, respectively [@bib8], [@bib9]. There have been articles describing quantitative determination of a few bioactive components for quality assessment of YZT [@bib10], [@bib11]. However, all of these achievements simply focused on one or several components, rather than the overall efficacy and quality of YZT. Moreover, there was no report on the quantitative and qualitative analysis of chemical fingerprint "common peaks" in the quality evaluation of YZT.

This paper describes, for the first time, a high performance liquid chromatography with diode array detector (HPLC-DAD) method for chemical fingerprint of YZT, and 40 "common peaks" were obtained. For those "common peaks", 10 compounds (protopine, jatrorrhizine, coptisine, palmatine, berberine, xanthotoxin, bergapten, tetrahydropalmatine, imperatorin and isoimperatorin) of them were simultaneously quantified and 33 compounds including 10 quantitative compounds ([Fig. 1](#f0005){ref-type="fig"}) were identified or tentatively characterized by electrospray ionization tandem mass spectrometry (ESI-MS/MS).Fig. 1Chemical structures of 33 identified compounds in Yuanhu Zhitong tablet (YZT).

2. Materials and methods {#s0010}
========================

2.1. Chemicals, reagents and materials {#s0015}
--------------------------------------

Acetonitrile (HPLC grade) was purchased from Fisher Scientific (Fisher Scientific, USA). Purified water was used from a Milli-Q system (Millipore, Bedford, MA, USA). All the other reagents were of analytical grade. The reference compounds of 10 quantitative analytes were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). The purities of these reference standards were determined to be higher than 98% by HPLC. Commercial products of YZT were collected from 12 pharmaceutical companies in China ([Table 1](#t0005){ref-type="table"}). The YZT from Manufacture A was selected for method optimization and validation of HPLC-DAD--ESI-MS/MS conditions.Table 1Summary of the tested YZT commercial samples.Sample no.ManufacturersBatch no.AGuangxi Tiantianle Pharmaceutical Co., Ltd., China100801BFoshan Dezhong Pharmaceutical Co., Ltd., China10012CGuangxi Shibiao Pharmaceutical Co., Ltd., China080901DSichuan Hebang Pharmaceutical Co., Ltd., China100901EHenan Wanxi Pharmaceutical Co., Ltd., China110502FJiangxi Jiulianshan Pharmaceutical Co., Ltd., China20101104GShandong Kongfu Pharmaceutical Co., Ltd., China100301HShandong Lukang Pharmaceutical Co., Ltd., China20110506INantong Jinghua Pharmaceutical Co., Ltd., China090701JShanxi Wanglong Pharmaceutical Co., Ltd., China20101001KSichuan Shuzhong Pharmaceutical Co., Ltd., China100906LGuangxi Banmu Tianlong Pharmaceutical Co., Ltd., China101001

2.2. HPLC-DAD--ESI-MS/MS {#s0020}
------------------------

HPLC analysis was performed on an Agilent 1260 series HPLC system. The analytes were isolated on an Agilent Eclipse plus C~18~ column (250 mm×4.6 mm i.d, 5 μm). The separation process followed a gradient elution procedure and used mobile phase A (0.4‰ ammonium acetate aqueous, pH 6.0 adjusted by glacial acetic acid) and B (acetonitrile) whose ratios changed linearly as follows: 0--25 min, 17--19% B; 25--55 min, 19% B; 55--70 min, 19--25% B; 70--80 min, 25--28% B; 80--95 min, 28--34% B; 95--120 min, 34--35% B; 120--140 min, 35--42% B; 140--160 min, 42--50% B. The flow rate was 1.0 mL/min. The injection volume was 5 μL and the column temperature was 30 °C. Quantitative detection wavelength was set, respectively, at 254 nm (xanthotoxin, bergapten, imperatorin and isoimperatorin), 270 nm (berberine), 280 nm (protopine and tetrahydropalmatine) or 345 nm (jatrorrhizine, coptisine and palmatine), while the wavelength of FA was set at 280 nm.

The above HPLC system was interfaced with an Agilent 6460 Triple Quadrupole mass spectrometer (Agilent Technologies, MA, USA) in a post-column splitting ratio of 4:1. The conditions of ESI source were as follows: source voltage, 3000 V; drying gas (N~2~) flow rate, 10.0 L/min; drying gas temperature, 320 °C; nebulizer, 25 psi. The MS data were acquired from *m*/*z* 100 to 1000 in positive ion modes.

2.3. Preparation of samples and NC solutions {#s0025}
--------------------------------------------

The coatings of YZT samples were removed completely, and the remaining were smashed into fine powder. Pulverized sample (1.0 g) was weighed precisely and ultrasonically extracted using 35 mL methanol for 30 min. After being settled to the volume of 50 mL, the extracted solution was filtered through filter paper and evaporated at 70 °C water bath. The residue was settled with methanol to the volume of 5 mL and centrifuged at 15,000 rpm for 10 min. The supernatant was filtered through a 0.45 μm membrane filter and transferred to an autosampler vial for HPLC-DAD--ESI-MS/MS analysis.

According to the prescription and preparation protocol of YZT formula recorded in China Pharmacopoeia (Ch. P.), two negative control (NC) samples without Radix *Angelicae dahuricae* or Rhizoma *Corydalis* were prepared, respectively, to validate the specificity of the method. The medicinal herbs were ground into powder in the particle size of 40--60 mesh and the negative samples were prepared according to the method described above for analysis.

2.4. Preparation of standard solutions {#s0030}
--------------------------------------

The 10 reference standards were weighed accurately. Jatrorrhizine, palmatine, coptisine and berberine were dissolved in methanol/water (50:50, v/v), and the other standards were dissolved in pure methanol. They were then diluted to appropriate concentrations for establishing calibration curves. All the solutions were stored in a refrigerator at 4 °C until use for analysis.

2.5. Quantitative and qualitative analysis in HPLC fingerprint {#s0035}
--------------------------------------------------------------

### 2.5.1. Confirmation of common peaks and evaluation of similarity {#s0040}

Data analysis was performed by a professional software named Similarity Evaluation System for Chromatographic Fingerprint of TCM (Version 2004A). The relative retention time (RTT) and relative peak area (RPA) of each common peak related to the reference peak were calculated for quantitative expression of the chemical properties in the chromatographic pattern of YZT. Based on this, the correlation coefficients of entire chromatographic profiles of samples were calculated, while the simulative mean chromatogram was generated.

### 2.5.2. Quantitative analysis validation of common peaks {#s0045}

The analysis of linearity, repeatability, stability, limit of detection (LOD) and limit of quantification (LOQ), precision, and accuracy were carried out to validate the quantitative method, following the International Conference on Harmonization (ICH) guideline [@bib12].

### 2.5.3. Qualitative analysis of common peaks {#s0050}

Identification of common peaks in YZT was carried out by LC--ESI-MS/MS analysis. In the full scan mass spectra, most of the constituents exhibited their quasi-molecular ions \[M+H\]^+^ in positive ion mode under the soft electrospray ionization condition. Precursor ions were subjected to collision-induced dissociation (CID) to generate the fragment ions and the fragmentation patterns were proposed for the structural identification of constituents.

3. Results and discussion {#s0055}
=========================

In an effort to control the quality of YZT, several excellent studies have been performed. Zhang et al. [@bib11] have determined and quantified 17 constituents in YZT in 9 min using rapid resolution liquid chromatography coupled with a triple quadrupole mass spectrometry. The sensitive and rapid analytical method has made contributions to the QC of YZT or herb medicines. However, this work just focused on the quantification of limited constituents and neglected the contributions of other constituents to YZT\'s squality and efficacy. Xu et al. [@bib13] employed ultra-performance liquid chromatography coupled with quadrupole time of flight tandem mass spectrometry (UPLC-Q-TOF-MS) to establish the chromatographic fingerprint and identify 18 common peaks of YZT. Their work gave an overall view of all the components in YZT, but the quantity variation of each ingredient was not revealed. Moreover, their outstanding work cannot be popularized in major laboratories due to costliness and limited application of LC--MS/MS. Our study employed HPLC-DAD to develop the chemical fingerprint and quantified 10 common peaks of YZT and utilized ESI-MS/MS to identify 33 common peaks. This combination of fingerprint with quantitative and qualitative analysis of common peaks for QC of YZT may serve as a significant reference for other laboratories and herb medicines.

3.1. Optimization of extraction conditions {#s0060}
------------------------------------------

In order to achieve the optimum extraction efficiency, extraction methods, solvents and their volumes, and extraction time were investigated. The results showed that pure methanol was the most efficient extraction solvent. In addition, refluxing extraction and ultrasonic extraction were compared for their popularity in extracting the targets from the matrix. It was found that ultrasonic extraction is more convenient and effective than refluxing extraction and it is difficult to destroy the active ingredient, and is suitable for rapid extraction of a large number of samples. The extraction time and sample-to-solvent ratio were also investigated. The results indicated that an efficient extraction described in the sample preparation was produced.

3.2. Optimization of chromatographic and mass spectrometric conditions {#s0065}
----------------------------------------------------------------------

In the present study, different mobile phases, such as acetonitrile or methanol and water containing ammonium acetate, formic acid and acetic acid, were tested. It was found that acetonitrile and ammonium acetate aqueous solution offered a more stable baseline, with more peaks detected and shorter duration of analysis than using other mobile phases. To improve the peak shape, restrain the peak tailing and increase ion response, the concentration and pH value of ammonium acetate aqueous solution were investigated. The findings suggest that the optimal elution was acetonitrile and 0.4‰ ammonium acetate aqueous solution (pH 6.0 adjusted with glacial acetic acid). In addition, we also evaluated 4 types of columns including Sepax GP-C~18~, Agilent Zorbax SB-C~18~, Kromasil C~18~ and Agilent Eclipse plus C~18~ columns. The best separation was achieved on the Agilent Eclipse plus C~18~ column.

The quantification of constituents in YZT was achieved at 254 nm for xanthotoxin, bergapten, imperatorin and isoimperatorin, 270 nm for berberine, 280 nm for protopine and tetrahydropalmatine and 345 nm for jatrorrhizine, coptisine and palmatine, where the UV spectra of the 10 analytes exhibited maximum absorbance and better response with less interference ([Fig. 2](#f0010){ref-type="fig"}A and B). In the FA, the wavelength was set at 280 nm where most chromatograph peaks were detected ([Fig. 2](#f0010){ref-type="fig"}B).Fig. 2Representative HPLC-DAD chromatograms of mixed standard solutions (A) at 254 nm, 270 nm, 280 nm and 345 nm; YZT (B) at 254 nm, 270 nm, 280 nm and 345 nm; the negative sample without Radix *Corydalis* (C) at 280 nm; and the negative sample without Rhizoma *Angelicae dahuricae* (D) at 280 nm. (3) protopine; (7) jatrorrhizine; (8) coptisine; (14) palmatine; (15) berberine; (20) xanthotoxin; (23) bergapten; (28) tetrahydropalmatine; (37) imperatorin; (40) isoimperatorin.

By comparing positive- and negative-ion modes, positive-ion mode was selected for MS analysis according to the number and abundance of peaks. Furthermore, optimal MS parameters including source voltage, drying gas (N~2~) flow rate and drying gas temperature were developed and the total ion current (TIC) chromatogram was acquired ([Fig. 3](#f0015){ref-type="fig"}A and B).Fig. 3HPLC--ESI-MS total ion chromatogram (TIC) in positive ion mode of (A) the mixed standard and (B) YZT.

3.3. Confirmation of common peaks and evaluation of similarity {#s0070}
--------------------------------------------------------------

According to the recommendation (Drug Administration Bureau of China, 2000), when peaks existed in all chromatograms of the samples and their relative standard deviation (RSD) values of RRT for all the 10 samples were less than 1%, these peaks could be assigned as the same substance and as a "common peak". Furthermore, the total area of the common peaks must be more than 90% of the whole area in one chromatogram.

Here, 12 YZT samples from different manufacturers were obtained and analyzed to perform FA following the established HPLC-DAD analysis procedure. The average chromatogram from the 12 samples was regarded as the standard fingerprint of YZT. As shown in [Fig. 4](#f0020){ref-type="fig"}, 40 peaks of all the peaks observed (\>90% of total area, denoted from 1 to 40) were defined as "common peaks". Peak 19 indicated the highest content in all the 40 peaks and was selected as a reference peak to calculate the RRT and RPA of common peaks. Their RSD values of RRT were less than 2.1%, which demonstrated good stability and reproducibility of the FA by HPLC-DAD. The similarity indexes of 12 samples calculated by fusion vector method were higher than 0.90, which suggested that the samples from different manufacturers shared a similar chromatographic pattern. However, the RSD values of RPA from the 12 samples were very high (approximately 23.5--130.91%), which might result from different origin, production process, storage conditions and alternative environment.Fig. 4The chromatogram of the investigated 12 samples of YZT.

3.4. Quantitative analysis of common peaks {#s0075}
------------------------------------------

### 3.4.1. Method validation {#s0080}

Ten peaks from "common peaks" with reasonable heights and good resolution were chosen as quantitative marker compounds. HPLC profiles of YZT and standard substances detected at 254 nm, 270 nm, 280 nm, and 345 nm are displayed in [Fig. 2](#f0010){ref-type="fig"}A and B, respectively.

In order to investigate the specificity of the method, different NC samples were prepared and analyzed, and the chromatograms are shown in [Fig. 2](#f0010){ref-type="fig"}C and D. It was noted that there were no interferences for 10 analytes.

Series of standard solutions of the 10 analytes were used to determine linear range. Calibration curves of the 10 analytes were generated by plotting peak areas versus the corresponding concentrations. The peak area values were the average of three replicate injections. Linearity of those calibration curves was evaluated through the application of a lack-of-fit test using the software SPSS 16.0. As shown in [Table 2](#t0010){ref-type="table"}, correlation coefficients were better than 0.999 for all analytes with Q values less than 3%. For the lack-of-fit test, the significance levels were greater than 0.05 for all analytes at the 95% confidence level, which indicated that a linear regression model provided a good interpolation of the experimental data. The LOD and LOQ were determined at S/N ratios of 3 and 10, respectively. The range of LOD for all compounds was from 0.03 to 0.11 μg/mL, and the range of LOQ was from 0.09 to 0.32 μg/mL ([Table 2](#t0010){ref-type="table"}).Table 2Detection wavelength, linear regression data, LOD, and LOQ for 10 active compounds in YZT analyzed by HPLC-DAD.Compound*λ* (nm)Linearity range (μg/mL)Calibration equation *y*=*ax*+*b*[a](#tbl2fna){ref-type="table-fn"}Correlation factor (*R*)*Q* (%)[b](#tbl2fnb){ref-type="table-fn"}*P* value[c](#tbl2fnc){ref-type="table-fn"}LOD[d](#tbl2fnd){ref-type="table-fn"} (μg/mL)LOQ[d](#tbl2fnd){ref-type="table-fn"} (μg/mL)Protopine2801.02--101.60*y*=21,104*x*−36,0990.99901.030.2180.060.19Jatrorrhizine3456.17--267.00*y*=10,661*x*−59,6120.99961.200.1140.110.32Coptisine3457.70--246.25*y*=21,514*x*--12,6710.99951.670.1570.080.24Palmatine3451.01--84.00*y*=85,389*x*−74,7420.99971.230.1330.030.11Berberine2701.00--83.50*y*=51,399*x*−69,4140.99971.880.0550.050.16Xanthotoxin2541.01--84.67*y*=53,658*x*−56,5380.99962.030.1540.040.15Bergapten2541.01--84.00*y*=37,976*x*−43,6380.99950.870.0930.070.20Tetrahydropalmatin28020.00--300.00*y*=13,534*x*+18,2670.99911.730.2230.090.29Imperatorin2541.01--84.67*y*=40,762*x*−36,4360.99970.560.0780.030.11Isoimperatorin2541.01--84.67*y*=26,478*x*−28,1650.99961.950.0980.050.16[^1][^2][^3][^4]

The precision of the proposed method was categorized into inter- and intra-day precision that can be determined from RSD for retention time and peak area resulting from the analysis of the studied compounds. In this study, the intra- and inter-day precision was analyzed using six duplicate experiments within 1 day or on 5 separate days. The RSDs of retention time and peak area were used to evaluate precision. The RSDs of intra- and inter-day precision of the 10 compounds were less than 2.0% for peak area and were less than 0.9% for retention time ([Table 3](#t0015){ref-type="table"}).Table 3Precision, repeatability and stability data of 10 analytes (RSD%, *n*=6).CompoundPrecisionRepeatabilityStabilityInter-dayIntra-dayRetention timePeak areaRetention timePeak areaRetention timeContentRetention timePeak areaProtopine0.41.90.51.20.71.80.40.8Jatrorrhizine0.51.10.80.71.11.60.51.2Coptisine0.71.70.91.40.91.50.40.9Palmatine0.61.70.71.01.41.70.61.3Berberine0.52.00.51.41.62.10.31.4Xanthotoxin0.61.90.41.31.51.70.61.2Bergapten0.50.90.31.00.62.00.50.9Tetrahydropalmatine0.41.30.51.61.22.20.70.8Imperatorin0.41.10.40.90.81.90.41.5Isoimperatorin0.31.00.60.71.11.60.61.1

The analytical repeatability was examined by injecting six different samples, which were prepared according to the same sample preparation procedure. The RSD of retention time and component content of the 10 analytes were used to estimate the repeatability. The results showed that the RSD values of retention time and component content for 10 analytes were less than 2.2% ([Table 3](#t0015){ref-type="table"}), which could meet the need of quantitative analysis.

For the stability test, retention time and peak area of the 10 analytes in a sample solution were analyzed every 8 h for over 2 days, and the sample solution was found to be stable within 48 h (RSD≤0.7% for retention time and RSD≤1.5% for peak area, [Table 3](#t0015){ref-type="table"}).

The accuracy of the method was determined through recovery measurement using the standard addition method. Three different quantities (low, medium and high) of the authentic standards were added to a sample which was previously analyzed and whose concentrations of the compounds of interest were known. The mixtures were extracted and analyzed using the optimized method. The quantity of each component was subsequently obtained by using the corresponding calibration plots. Each set of additions was repeated three times. The results from determination of recovery are expressed as the percentage of the analytes recovered by the assay. The recovery of the components ranged from 98.9% to 102.3% and all of the RSD were less than 2.5% ([Table 4](#t0020){ref-type="table"}), which indicates the method ensures high accuracy for simultaneous analysis of the 10 compounds.Table 4Recovery of each analyte determined by standard addition method (*n*=3).CompoundOriginal amount (μg)Spiked amount (μg)Found amount (μg)Recovery (%)Average recovery (%)RSD (%)Protopine93.5346.77139.4699.4101.31.693.53190.80102.0140.00239.13102.4Jatrorrhizine6.803.409.9997.9100.72.56.8014.00102.910.0017.00101.2Coptisine74.0037.50112.76101.1102.31.074.00152.58103.1112.00191.12102.8Palmatine105.2352.62156.8299.498.90.4105.00207.7898.8157.62259.0598.6Berberine55.5027.7582.9899.9100.81.055.50112.27101.183.00140.61101.5Xanthotoxin4.622.326.8999.399.90.94.709.2899.67.0011.73101.0Bergapten48.8424.4272.7299.399.90.850.0099.62100.874.42122.9099.7Tetrahydropalmatine186.7593.38281.74100.6101.20.5187.00378.71101.3280.00474.20101.6Imperatorin79.8339.92119.2499.6100.40.980.00161.95101.3120.00200.48100.3Isoimperatorin93.0646.53140.82100.9101.00.193.00187.99101.0140.00235.50101.1

### 3.4.2. Quantification of YZT samples {#s0085}

This established analytical method was subsequently applied for simultaneous determination of 10 quantitative analytes in 12 commercial samples of YZT. Each sample was determined in triplicate. Peaks in the chromatograms were identified by comparing the retention times, on-line UV spectra and MS data with those of the standards.

The HPLC-DAD profiles of YZT are illustrated in [Fig. 4](#f0020){ref-type="fig"} and the contents of the 10 analytes are shown in [Table 5](#t0025){ref-type="table"}. It was found that the content of each analyte varied greatly among different samples. According to the provision of Ch. P. [@bib7], the content of tetrahydropalmatine should not be less than 300 µg/g. Although all analyzed samples meet the requirement, the content of tetrahydropalmatine, however, varied from 319.45 µg/g to 1159 µg/g (RSD%=71.5). A similar variation could also be found for the other components such as berberine, xanthotoxin, bergapten, imperatorin, and isoimperatorin. The variation in the content of constituents could certainly lead to the variation of therapeutic effects. Therefore, the detection of a single component or only several components could not effectively control the quality of YZT.Table 5Amounts of the 10 compounds in YZT from different manufacturers.SampleAmount (µg/g, mean±SD, *n*=3)ProtopineJatrorrhizineCoptisinePalmatineBerberineXanthotoxinBergaptenTetrahydropalmatineImperatorinIsoimperatorinA104.25±0.3042.75±0.06327.95±0.0448.15±0.00560.25±0.2435.40±0.0389.75±0.05319.45±0.1575.35±0.0632.30±0.003B112.85±0.2295.05±0.07293.10±0.06139.70±0.008331.00±0.15−31.80±0.007346.00±0.2680.10±0.0547.80±0.004C141.40±0.0677.20±0.004369.40±0.005212.35±0.00247.30±0.07−26.05±0.003627.50±0.09240.20±0.17126.25±0.07D121.75±0.5468.50±0.07219.35±0.007148.35±0.0734.90±0.056.55±0.00632.05±0.04977.25±0.13197.65±0.041013.50±0.09E120.00±0.3889.80±0.003376.00±0.04149.05±0.0357.60±0.038.60±0.00929.55±0.06418.05±0.0982.80±0.00346.80±0.006F83.75±0.0876.50±0.005361.95±0.005141.65±0.0653.75±0.00910.40±0.1481.40±0.121297.25±0.06191.05±0.005137.45±0.007G148.60±0.0773.45±0.01361.50±0.006103.70±0.2152.95±0.0046.75±0.0533.60±0.04431.06±0.002294.25±0.02141.95±0.004H35.90±0.0344.30±0.002207.55±0.00746.40±0.0419.95±0.0612.25±0.0723.35±0.07702.10±0.04195.50±0.006121.25±0.09I170.25±0.0680.30±0.004512.15±0.008140.05±0.00959.40±0.086.90±0.0426.70±0.06382.85±0.03160.35±0.00783.50±0.08J141.40±0.0786.05±0.14477.70±0.02153.70±0.0468.90±0.00211.35±0.0638.60±0.10360.90±0.0396.90±0.00346.40±0.001K145.10±0.0976.70±0.01573.65±0.09117.40±0.1053.20±0.078.40±0.0842.90±0.25322.35±0.04372.05±0.002271.75±0.02L33.30±0.0645.40±0.05140.00±0.0158.95±0.0827.15±0.00321.40±0.4354.75±0.091159.00±0.09401.65±0.004295.90±0.06RSD%38.225.136.340.8114.690.051.571.556.1137.5[^5][^6]

3.5. Qualitative analysis of common peaks {#s0090}
-----------------------------------------

Thirty-three common peaks described in the fingerprint chromatogram including 10 quantitative compounds were identified or tentatively characterized, and their ESI-MS/MS data and fragmentations are listed in [Table 6](#t0030){ref-type="table"}.Table 6Characterization of 33 identified compounds in YZT by HPLC-DAD--ESI-MS/MS.Peak No.RT (min)IdentificationEmpirical formulaUV *λ*max (nm)(+)ESI-MS (*m*/*z*)MS/MS (*m*/*z*)114.37ScopoletinC~10~H~8~O280193.0(M+H)177.6(M+H-CH~3~); 149.1(M-CH~3~-CO); 132.5(M-CH~3~-CO-OH)219.89YuanhunineC~21~H~25~NO~4~280356.00 (M+H)340 (M-CH~3~); 192 (M+H-C~10~H~12~O~2~)325.02ProtopineC~20~H~19~NO~5~280354.0(M+H)275.0(M+H-CH~3~-NH~2~-CH~2~(OH)~2~); 189.0(M+2H-149-OH); 148.9(M+2H-C~11~H~13~O~3~N)427.55α-AllocryptopineC~21~H~23~NO~5~280370.2(M+H)289.9(M+H-2CH~3~O-OH); 206.0(M+H-C~10~H~12~O~2~); 187.9(M+H-C~10~H~12~O~2~-H~2~O)530.83CorydalineC~22~H~27~NO~4~270370.3(M+H)354.0(M-CH~3~); 206.2(M+H-C~10~H~12~O~2~); 192.1(M+H-C~11~H~15~O~2~); 164.8(M-C~11~H~14~O~2~N)632.39ColumbamineC~20~H~20~NO~4~^+^280338.9(M+H)323.3(M-CH~3~); 308.8(M-2CH~3~); 294.9(M-CH~3~-CO)733.61JatrorrhizineC~20~H~20~NO~4~^+^345338.3(M+H)322.9(M-CH~3~); 308.0(M+H-CH~3~O); 294.0(M+H-3CH~3~); 190.0(M+H-C~9~H~9~O~2~)836.13CoptisineC~19~H~14~NO~4~^+^345320.1(M)292.0(M-CO); 262.0(M+H-CO-CH~3~O); 234.0(M-2CO-CH~3~O)941.445-Methoxy-8-hydroxypsoralenC~12~H~8~O~5~270233.2(M+H)218.0(M+H-CH~3~); 190.0(M-CH~3~-CO); 162.01(M-CH~3~-2CO)1251.56Oxypeucedanin hydrateC~16~H~16~O~6~254305.0(M+H)203.02(M+H-C~5~H~9~O-OH); 147.0(M+H-C~5~H~9~O-2CO)1360.63EpiberberineC~20~H~18~NO~4~^+^270336.2(M)319.8(M+H-OH); 292.0(M+H-CO-OH)1462.82PalmatineC~21~H~22~NO~4~^+^345352.4(M)336.4(M-H-CH~3~); 322.4(M-2CH~3~); 308.4(M-H-CH~3~-CO)1565.32BerberineC~20~H~18~NO~4~^+^270335.9(M)320.0(M-CH~4~); 292.0(M-CH~4~-CO); 278.0(M-2CH~3~-CO)1667.70ByakangelicolC~17~H~16~O~6~280317.4(M+H)231.0(M+H-C~5~H~10~O); 202.9(M+H-C~5~H~10~O-CO); 188.1(202.9-CH~3~); 175.9(202.9-CO)1767.70ByakangelicinC~17~H~18~O~7~280335.3(M+H)231.5(M+H-C~5~H~10~O); 217.9(M+H-C~5~H~10~O-CH~3~); 202.9(231.3-CO); 175.2(231.3-2CO)1975.70DehydrocorydalineC~22~H~24~NO~4~^+^270366.1(M+H)350.1(M-CH~3~); 335.9(M+H-2CH~3~); 321.9(M+2H-3CH~3~)2077.84XanthotoxinC~12~H~8~O~4~254216.9(M+H)201.9(M+H-CH~3~); 173.9(M+H-CO-CH~3~); 160.9(M+H-2CO); 145.8(M+H-2CO-CH~3~)2181.55GlaucineC~21~H~25~NO~4~280356.0(M+H)325.02(M+H-CH~3~O); 294.0(M+H-2CH~3~O); 279.0(M+H-2CH~3~O-CH~3~)2390.05BergaptenC~12~H~8~O~4~254216.9(M+H)201.9(M+H-CH~3~); 173.9(M+H-CO-CH~3~); 146.0(M+H-2CO-CH~3~)2491.97IsopimpinellinC~13~H~10~O~4~270247.0(M+H)232.0(M+H-CH~3~); 217.1(M+H-2CH~3~); 188.8(M+H-2CH~3~-CO)26101.80PabulenolC~16~H~14~O~5~254287.6(M+H)203.0(M+H-C~5~H~9~O); 174.7(M+H-C~5~H~9~O-CO); 146.7(M+H-C~5~H~9~O-2CO)28108.05TetrahydropalmatineC~21~H~25~NO~4~280356.0(M+H)192.0(M+H-C~10~H~12~O~2~); 165.0(M+H-C~11~H~13~O~2~N)29112.01OxypeucedaninC~16~H~14~O~5~280287.5(M+H)203.1(M+H-C~5~H~9~O); 147.0(M+H-C~5~H~9~O-2CO)30115.29RotundineC~21~H~25~NO~4~280356.0(M+H)191.7(M+H-C~10~H~12~O~2~); 164.9(M+2H-C~11~H~13~O~2~N)31118.02ApaensinC~17~H~16~O~6~270317.0(M+H)233.1(M+2H-C~5~H~9~O); 218.1(M+2H-C~5~H~9~O-CH~3~); 203.0(M+2H-C~5~H~9~O-2CH~3~); 175.0(M+2H-C~5~H~9~O-2CH~3~-CO)32120.057-DemethylsuberosinC~14~H~14~O~3~270231.00 (M+H)203.00(M+H-CO); 187.90(M+H-CO~2~); 175.00(M-C~4~H~8~); 159.90(M+H-CO~2~-CO); 146.90(M-C~4~H~8~-CO)34128.46AlloimperatorinC~16~H~14~O~4~270271.0(M+H)229.2(M+H-C~3~H~6~); 214.8(M+H-C~4~H~8~); 186.8(M+H-C~4~H~8~-CO)35131.92TetrahydroberberineC~20~H~21~NO~4~270340.20 (M+H)176 (M+H-C~10~H~12~O~2~); 149(M+H-CH~3~-C~10~H~10~O~2~N)36142.13BergaptolC~11~H~6~O~4~280203.00 (M+H)159(M+H-CO~2~); 147(M+H-2CO); 131(M+H-CO~2~-CO); 119(M+H-2CO-CO)37147.29ImperatorinC~16~H~14~O254271.0(M+H)202.9(M+H-C~5~H~8~); 174.9(M+H-C~5~H~8~-CO); 146.9(M+H-C~5~H~8~-2CO); 130.9(146.9-CH~4~)38152.03XanthotoxolC~11~H~6~O~4~280203.0(M+H)175.0(M+H-CO); 146.9(M+H-2CO); 130.8(M+H-CO-CO~2~)39154.16CnidilinC~17~H~16~O~5~270301.0(M+H)233.1(M+H-C~5~H~8~); 218.0(M+H-C~5~H~8~-CH~3~)40158.37IsoimperatorinC~16~H~14~O~4~254271.0(M+H)202.9(M+H-C~5~H~8~); 158.8(M+H-C~5~H~8~-CO~2~); 146.9(M+H-C~5~H~8~-2CO); 130.9(146.9-CH~4~)

### 3.5.1. Identification of fifteen alkaloids from Rhizoma Corydalis {#s0095}

For protopine and tetrahydroprotoberberine alkaloids, their characteristic fragmentation pathway was Retro-Diels--Alder (RDA) rupture [@bib14]. Compound 3 gave protonated molecular ion \[M+H\]^+^ (*m*/*z* 354) in positive-ion mode. The RDA rupture from \[M+H\]^+^ may produce fragment ions at *m*/*z* 149 and *m*/*z* 206. The fragment ion at *m*/*z* 189 might be due to the loss of OH from the fragment ion at *m*/*z* 206. By comparing the UV and MS spectra with those of the reference standard, compound 3 was unequivocally identified as protopine [@bib10], [@bib14]. Similarly, compound 4 yielded \[M+H\]^+^ at *m*/*z* 370 and a series of ions including \[M+H-C~10~H~12~O~2~\]^+^ at *m*/*z* 206, \[M+H-C~10~H~12~O~2~-H~2~O\]^+^ at *m*/*z* 188, \[M+H-H~2~O\]^+^ at *m*/*z* 352 and \[M+H-2CH~3~O-OH\]^+^ at *m*/*z* 290, which was tentatively identified as α-allocryptopine [@bib10], [@bib14]. The MS/MS data of compound 5 revealed its main fragmentation, which was the successive losses of CH~3~, C~10~H~12~O~2~, C~11~H~15~O~2~, C~11~H~14~O~2~N, yielding product ions at *m*/*z* 354, 206, 192 and 165, corresponding to the structure of corydaline [@bib15], [@bib16]. Compound 35 produced \[M+H\]^+^ ion at *m*/*z* 340, fragment ions \[M+H-C~10~H~12~O~2~\]^+^ at *m*/*z* 176 and \[M+H-CH~3~-C~10~H~10~O~2~N\]^+^ at *m*/*z* 149. Therefore, it can be identified as tetrahydroberberine [@bib10].

Four compounds had the same \[M+H\]^+^ ions at *m*/*z* 356 (compounds 2, 21, 28, and 30). Compound 2, 28 and 30 all produced fragment ion \[M+H-C~10~O~2~H~12~\]^+^ at *m*/*z* 192, which resulted from the RDA rupture of tetrahydroprotoberberine alkaloids [@bib14]. Compound 28 was confirmed as tetrahydropalmatine after comparing with a reference standard and literature [@bib14], [@bib16]. Compound 30 had the same characteristic fragmentation pathway, but its retention time was different from that of tetrahydropalmatine. Therefore, it was tentatively identified as rotundine. Compound 2 was tentatively identified as yuanhunine referring to the literature [@bib17]. Compound 21 gave an ion \[M+H-2OCH~3~\]^+^ at *m*/*z* 294 as significant ion with a further fragment \[M+H-2OCH~3~-CH~3~\]^+^. However, \[M+H-OCH~3~-CH~3~\]^+^ was observed without any further fragmentation. Thus it was identified as glaucine [@bib16], [@bib18].

Quaternary alkaloids gave \[M\]^+^ ions. For example, compounds 14 and 15 were easily identified as palmatine and berberine by comparing the retention time, \[M\]^+^ ions and the characteristic fragment ions with those data of the corresponding authentic standards [@bib19], [@bib20]. Compound 13 produced \[M+H\]^+^ at *m*/*z* 336 and had similar characteristic fragment ions at *m*/*z* 320 and 292 with berberine, it was tentatively determined as epiberberine [@bib19], [@bib20]. Compound 19 produced an \[M+H\]^+^ ion at *m*/*z* 366, \[M-CH~3~\]^+^ ion at *m*/*z* 350 and \[M+2H-3CH~3~\]^+^ ion at *m*/*z* 322, and further yielded the fragment ion \[M+H-2CH~3~\]^+^ at *m*/*z* 336, corresponding to the structure of dehydrocorydaline [@bib9], [@bib16].

Compound 6 displayed \[M+H\]^+^ ion at *m*/*z* 339 and the fragment ions of losing CH~3~, 2CH~3~ and CH~3~CO were observable. Compared with the literature [@bib21], it was identified as columbamine. Compound 7 gave the molecular ion \[M+H\]^+^ at *m*/*z* 339. \[M-CH~3~\]^+^ at *m*/*z* 323, \[M+H-CH~3~O\]^+^ at *m*/*z* 308 and \[M+H-3CH~3~\]^+^ at *m*/*z* 294 were also observed in the product-ion spectra. The molecular mass of compound 8 was 320. The precursor ion \[M\]^+^ at *m*/*z* 320 gave prominent product ions at *m*/*z* 292, 262 and 234. Therefore, compounds 7 and 8 were unequivocally identified as jatrorrhizine and coptisine by comparing the UV and MS spectra with those of the reference standards [@bib19].

### 3.5.2. Identification of two simple coumarin from Radix Angelicae dahuricae {#s0100}

Compound 1 provided the fragment ions at *m*/*z* 178 by losing methyl group from the \[M+H\]^+^, together with the ions \[M-CH~3~-CO\]^+^ at *m*/*z* 149 and \[M-CH~3~-CO-OH\]^+^ at *m*/*z* 132, which could be tentatively identified as scopoletin [@bib10], [@bib22]. Compound 32 was tentatively speculated as 7-demethylsuberosin, which can give \[M+H\]^+^ ion at *m*/*z* 231. The base peak was the fragment ion \[M-C~4~H~8~\]^+^ at *m*/*z* 175, which may result from the benzyl rupture of \[M+H\]^+^ ion. The fragment ions at *m*/*z* 203, 187, 159 may be the loss of \[CO\], \[CO~2~\], \[CO~2~+CO\] from \[M+H\]^+^, while *m*/*z* 147 may be the loss of \[CO\] from \[M-C~4~H~8~\]^+^ [@bib23].

### 3.5.3. Identification of 16 furocoumarins from Radix Angelicae dahuricae {#s0105}

Sixteen furocoumarins exhibited their quasi-molecular ions \[M+H\]^+^ and contained product ions formed by the loss of CO and CO~2~ from the furocoumarin skeleton or C~5~H~9~O, C~5~H~8~, CH~3~ from the substituent groups at C-5 or C-8. Most substituent groups at C-5 or C-8 of the linear-type furocoumarins were oxysubstituent groups, and different substituent sites possess different fragmentation patterns [@bib24].

If isopentenoxy group was at C-5 and no substituent was at C-8, such as isoimperatorin (compound 40), the ESI-MS spectrum exhibited an \[M+H\]^+^ ion of *m*/*z* 271 as the base peak. The \[M+H\]^+^ ion was further fragmented by neutral loss of a rearranged isopentenyl moiety, leading to the formation of a predominant ion \[M+H-C~5~H~8~\]^+^ at *m*/*z* 203, produced ions \[M+H-C~5~H~8~-CO~2~\]^+^ at *m*/*z* 159, \[M+H-C~5~H~8~-2CO\]^+^ at *m*/*z* 147 and \[147-CH~4~\]^+^ at *m*/*z* 131[@bib25]. Its identification was further confirmed by comparison with an authentic compound. Compounds 26 and 29 had the same quasi-molecular and similar fragment ions in MS/MS spectra, in which the consecutive neutral losses of C~5~H~9~O and C~5~H~9~O-2CO from \[M+H\]^+^ of *m*/*z* 288 were observed. Since they showed different retention behavior on column, compound 26 was identified as pabulenol while compound 29 was attributed to oxypeucedanin [@bib24]. Meanwhile, compound 12 had the same produced ions at *m*/*z* 203 and 147 with compound 29, the \[M+H\]^+^ of which was 305. Therefore, compound 12 was preliminarily identified as oxypeucedanin hydrate [@bib22], [@bib25].

Compounds 20 and 23 displayed \[M+H\]^+^ ion at *m*/*z* 217 and same fragment ion \[M+H-CH~3~\]^+^ at *m*/*z* 201, \[M+H-CH~3~-CO\]^+^ at *m*/*z* 174 and \[M+H-CO\]^+^ at *m*/*z* 146. Compared with the standard, compounds 20 and 23 were identified as xanthotoxin and bergapten, respectively [@bib26].

If alkoxy moieties at C-5 and C-8, the compound, like 5-methoxy-8-hydroxypsoralen (compound 9), could give the protonated ion \[M+H\]^+^ at *m*/*z* 233, which was further fragmented by the losses of methyl group and the successive carbonyl group, leading to the product ions \[M+H-CH~3~\]^+^ at *m*/*z* 218, \[M+H-CH~3~-CO\]^+^ at *m*/*z* 190 and \[M+H-CH~3~-2CO\]^+^ at *m*/*z* 162 [@bib24], [@bib27]. Similarly, with the parent ion at *m*/*z* 247 and fragment ions at *m*/*z* 232 \[M+H-CH~3~\]^+^ and 217 \[M+H-2CH~3~\]^+^, compound 24 was identified as isopimpinellin [@bib24], [@bib27]. Compound 16 yielded \[M+H\]^+^ at 317, \[M+H-C~5~H~10~O\]^+^ at *m*/*z* 231, \[M+H-C~5~H~10~O-CO\]^+^ at *m*/*z* 203 and \[203-CO\]^+^ at *m*/*z* 175. It was identified as byakangelicol [@bib27], [@bib28]. Compound 31 yielded the same \[M+H\]^+^ at 317 with compound 16, but had different fragment ions \[M+H-C~5~HO~8~\]^+^ at *m*/*z* 233 and \[M+H-C~5~HO~8~-CH~3~\]^+^ at *m*/*z* 218. So it was identified as apaensin [@bib27]. Compound 17 gave the fragment ions \[M+H\]^+^ at *m*/*z* 335, \[M+H-C~5~H~10~O~2~\]^+^ at *m*/*z* 231 and \[M+H-C~5~H~12~O~2~-CH~3~\]^+^ at *m*/*z* 218, which strongly suggests the presence of byakangelicin [@bib22]. Cnidilin (compound 39) was detected with \[M+H\]^+^ at *m*/*z* 301, fragment ions at *m*/*z* 233 and \[233-CH~3~\]^+^ at *m*/*z* 218 [@bib29].

If isopentenoxy group was at C-8 and no substituent was at C-5, such as imperatorin (compound 37), the protonated molecular ion of *m*/*z* 271 was observed in ESI-MS spectrum, and loss of a rearranged isopentenyl fragment ion \[M+H-C~5~H~8~\]^+^ at *m*/*z* 203 of protonated molecular was also observed. Ion \[M+H-C~5~H~8~-CO\]^+^ at *m*/*z* 175 and \[M+H-C~5~H~8~-2CO\]^+^ at *m*/*z* 147 were produced in MS/MS analysis. Compounds 36 and 38 both produced \[M+H\]^+^ at *m*/*z* 203, fragment ions \[M+H-2CO\] at *m*/*z* 147 and \[M+H-CO~2~-CO\]^+^ at *m*/*z* 131. \[M+H-CO~2~\]^+^ at *m*/*z* 159 was found in product ions of compound 36 while \[M+H-CO\]^+^ at *m*/*z* 175 in compound 38, so they were respectively identified as bergaptol and xanthotoxol [@bib26]. Compound 34 exhibited a minor \[M+H\]^+^ ion at *m*/*z* 271 and predominant fragment ion \[M+H-C~3~H~6~-H~2~O\]^+^ at *m*/*z* 223, \[M+H-C~4~H~8~\]^+^ at *m*/*z* 215 and \[M+H-C~4~H~8~-CO\]^+^ at *m*/*z* 187. So it could be tentatively identified as alloimperatorin [@bib30].

4. Conclusion {#s0110}
=============

In the present work, a reliable and efficient HPLC-DAD--ESI-MS/MS method was established for the QC of YZT by quantitative and qualitative analysis of "common peaks" in chemical fingerprint. For 40 common peaks in YZT, 10 analytes were simultaneously quantified and good linearity, precision, repeatability, stability and recovery were obtained. Thirty-three components including the 10 quantitative compounds were successfully identified on the basis of retention time and MS/MS spectra after being compared with those of standards or literature. The present study provided comprehensive information not only for pharmacological researches and clinical applications, but also for quality evaluation of YZT.
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[^1]: In the regression equation *y*=*ax*+*b*, *x* is the concentration of the compound (μg/mL), *y* indicates the peak area, and *R* is the correlation coefficient of the equation.

[^2]: Quality coefficient of the regression model.

[^3]: *P* value of lack-of-fit test (confidence level at 95%).

[^4]: The LOD was defined as the concentration for which the signal-to-noise ratio was 3; the LOQ was defined as the concentration for which the signal-to-noise ratio was 10.

[^5]: −: Lower than limit of quantification.

[^6]: RSD: variation of mean amount of each compound.
